CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Alleviating staff shortages by empowering surgeons with greater personalization and control
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The hospital in association with ‘We Warriors’ and ‘Dev Bhumi Rakshak Foundation’ organized First Aid and CPR training session for youngsters and volunteers
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Subscribe To Our Newsletter & Stay Updated